tm logo
Trademark Search
TRIGENESIS

View On IC.GC.CA

TRIGENESIS
ABANDONED SECTION 36

on 10 Jan 2023

Last Applicant/ Owned by

SAREPTA THERAPEUTICS INC.

215 First StreetCambridge MA 02142

US

Serial Number

2066764 filed on 20th Jul 2020

TRIGENESIS

Trademark usage description

pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disor Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform; pharmaceutical preparations that modulate RNA expression; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations, biological preparations and gene therapy products for the treatment of genetic disorders and diseases.

Classification kind code

11

Class [016]
Printed materials, namely, brochures, leaflets, reports, and newsletters on the topics of medicine, medical research, scientific research, research and development of pharmaceuticals, biological preparations and gene therapy products, rare and infectious diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders.

Classification kind code

11

Class [042]
Medical research; medical and scientific research services all in the field of rare and infectious diseases; medical and scientific research services all in the field of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, and genetic diseases and disorders; medical and scientific research services all in the field of gene therapy, gene editing, genome editing, viruses, viral vectors, and viral constructs; providing information in the field of medical research, scientific research, research and development relating to pharmaceuticals, biological preparations and gene therapy products, rare and infectious diseases, neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, genetic therapy research, and diagnosis and treatment of genetic disorders via a website.

Classification kind code

11

Class [044]
Medical information services; providing medical information via a website; provision of health care services, namely, providing information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options.

Classification kind code

11

Mark Details

Serial Number

2066764

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 14
on 18th Oct 2022		Default Notice Sent
Submitted for opposition 22
on 29th Mar 2022		Search Recorded
Submitted for opposition 20
on 29th Mar 2022		Examiner's First Report
Submitted for opposition 223
on 29th Mar 2022		Total Provisional Refusal
Submitted for opposition 256
on 27th Sep 2021		Notification of Possible Opposition Sent
Submitted for opposition 1
on 30th Nov 2020		Created
Submitted for opposition 31
on 30th Nov 2020		Formalized
Submitted for opposition 257
on 26th Nov 2020		Designation Notification - Madrid Protocol
Submitted for opposition 30
on 20th Jul 2020		Filed
Submitted for opposition 228
on 20th Jul 2020		International Registration